Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Competitors and Similar CompaniesClear all

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical's competitors and similar companies include GeneDx, Ginkgo Bioworks Holdings, Blueprint Genetics and Poseida Therapeutics.

	Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Shanghai Fudan-Zhangjiang Bio-Pharmaceutical is a company that manufactures biomedicine.	GeneDx GeneDx is a company operating in the genetics and genomics industry.	Ginkgo Bioworks Holdings Ginkgo Bioworks Holdings is a company that designs and develops genetic technology solutions.	Blueprint Genetics Blueprint Genetics provides clinical gene testing and customized next-generation sequencing services.	Poseida Therapeutics Poseida Therapeutics utilizes best-in-class genome engineering capabilities to develop targeted lifesaving therapeutics.
Founding Date	Founding Date 1996	Founding Date 2000	Founding Date 2020	Founding Date 2012	Founding Date 2015
Type	Type Public	Type Subsidiary	Type Public	Type Private	Type Public
Tags	Tags Healthcare biotech genetics	Tags Healthcare biotech genetics	Tags Technology biotech genetics	Tags Healthcare biotech genetics	Tags Healthcare biotech genetics
Locations	Locations CN HQ	Locations Gaithersburg, US HQ	Locations Boston, US HQ	Locations Esbo, FI HQ Dubai, AE Seattle, US	Locations San Diego, US HQ
Employees	Employees 921	Employees 8964% increase	Employees 1,2186% decrease	Employees 2191% decrease	Employees 3111% decrease
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $170.2m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) $64.7m (FY, 2023)
Net income	Net income N/A	Net income N/A	Net income ($312.8m) (FY, 2025)	Net income N/A	Net income ($123.4m) (FY, 2023)
Funding
Total funding raised	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 789.1m	Total funding raised $ 26.3m	Total funding raised $ 336.5m